OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
14
Results
Show all
Save search
Copy query
Show results for
Unknown
(14)
Publication Date
Release Date
2023
(5)
2022
(3)
2024
(2)
2025
(1)
2021
(1)
2020
(1)
2018
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
The effects of differing anticoagulant regimes on blood quality after cell salvage in coronary artery bypass grafting (CABG): a pilot study.
Not available
S-EPMC10082980
|
biostudies-literature
Cite
Phasing out DEHP from plastic indwelling medical devices used for intensive care: Does it reduce the long-term attention deficit of critically ill children?
Not available
S-EPMC8685605
|
biostudies-literature
Cite
Identification of Potential Urinary Metabolite Biomarkers of
Pseudomonas aeruginosa
Ventilator-Associated Pneumonia.
Not available
S-EPMC9112676
|
biostudies-literature
Cite
Dysregulated activities of proline-specific enzymes in septic shock patients (sepsis-2).
Not available
S-EPMC7173796
|
biostudies-literature
Cite
Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients: the AdrenOSS-2 phase 2a biomarker-guided trial.
Not available
S-EPMC8487806
|
biostudies-literature
Cite
Convalescent Plasma for Covid-19-Induced ARDS in Mechanically Ventilated Patients.
Not available
S-EPMC10755833
|
biostudies-literature
Cite
The impact of a summative national prescribing assessment and curriculum type on the development of the prescribing competence of junior doctors.
Not available
S-EPMC10663181
|
biostudies-literature
Cite
Clinical and molecular epidemiological features of critically ill patients with invasive group A Streptococcus infections: a Belgian multicenter case-series.
Not available
S-EPMC10825083
|
biostudies-literature
Cite
Decontamination Strategies and Bloodstream Infections With Antibiotic-Resistant Microorganisms in Ventilated Patients: A Randomized Clinical Trial.
Not available
S-EPMC6583563
|
biostudies-literature
Cite
Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.
Not available
S-EPMC9451499
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets